The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study

Laura Cantu'1, Laura Colombo2, Tatiana Stoilova2

  • 1Department of Medical Biotechnology and Translational Medicine, University of Milan, LITA, Segrate, 20090, Milano, Italy.

Scientific Reports
|July 16, 2017
PubMed
Summary

A novel APP gene mutation (A673V) causes early-onset Alzheimer's disease (AD) in homozygous individuals but protects heterozygotes. This A673V mutation alters amyloid-beta (Aβ) aggregation and fibril structure.